Coordinated selling by both the CEO and CFO raises concerns about confidence in near-term prospects. Traders should monitor upcoming earnings, guidance, and any changes in cash burn or revenue trends closely.
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Feb 23 $18.89entry
- T+1 · 9mo ago +1.11%α +0.38% · $19.10
- T+5 · 9mo ago +22.50%α +21.88% · $23.14
- T+20 · 8mo ago +1.32%α +5.27% · $19.14
- T+60 · 6mo ago +13.55%α +5.30% · $21.45
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three 10x Genomics insiders, including CEO Serge Saxonov and CFO Adam Taich, sold shares in a coordinated open-market transaction on February 23, 2026, collectively disposing of 26,426 shares for approximately $490,900. The sales were conducted at the same price and date, indicating a planned divestment by top executives.
Key Financial Metrics
Key Facts
- CEO Serge Saxonov sold 9,632 shares for $178,928 in open-market transaction.
- CFO Adam Taich sold 8,968 shares for $166,593 in open-market transaction.
- Benjamin J. Hindson (former CEO, per remarks) sold 7,826 shares for $145,379.
- All three sales occurred on the same day at identical price, suggesting coordination.
- Total insider sell volume: 26,426 shares, valued at ~$490,900.
Financial Impact
$490,900 in insider selling by C-suite executives
Risk Factors
- Loss of executive confidence in stock price or business trajectory
- Potential for further insider selling
- Downside pressure on share price if institutional investors interpret this as a negative signal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-TXG-1772109092542 |
Track record
28 reports on TXG
1 of 5 bullish or bearish reports moved the stock their way by T+60. Best: +8.89% at T+60 after the Aug 19, 2026 report. 2 of 6 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $55.40 Now $54.99 −0.74% settles Feb 12
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 6, 202610d ago 3 Neutral 1/10 Entry $65.05 Now $54.99 −15.47% settles Feb 5
- Nov 5, 202611d ago 8-K Bullish 6/10 No price data
- Nov 5, 202611d ago Press Release Mixed 5/10 Entry $59.28 Now $54.99 −7.24% settles Feb 4
- Nov 2, 202614d ago 8-K Neutral 2/10 Entry $65.29 Now $54.99 −15.78% settles Feb 1
- Oct 23, 202624d ago Institutional Cluster Neutral 2/10 Entry $71.55 Now $54.99 −23.14% settles Jan 21
- Oct 7, 20265w ago SC 13G/A Neutral 2/10 Entry $77.28 Now $54.99 −28.84% settles Jan 5
- Sep 24, 20267w ago Insider Cluster Neutral 3/10 Entry $85.71 Now $54.99 −35.84% settles Dec 21
- Sep 22, 20267w ago 144 Neutral 2/10 Entry $75.62 Now $54.99 −27.28% settles Dec 17
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers